Search Results 731-740 of 17571 for Assay

1. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   difficile stool assay by EIA for Toxin A and/or B performed at the local laboratory or a study specific assay performed at the central laboratory. Women of ...

2. Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML - Mayo Clinic

   * Participants with newly diagnosed AML with FLT3-ITD mutations (FLT3-ITD \[+\]) present at ≥5% VAF (or ≥0.05 SR) based on a validated FLT3 mutation assay.

3. Alumni Profiles - Clinician Investigator Training Program - Mayo Clinic College of Medicine & Science

   Brad Anderson, M.D.. Chief Resident, Clinician Investigator Training Program. Clinician Investigator research: Detection of gastric cancer by assay of novel ...

4. Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer that has been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) - Mayo Clinic

   ... assay and defined by an increase in the distance between 5' and 3' ALK probes or the loss of the 5' probe; this must have been performed: By a local ...

5. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   ... assays used will range from single gene abnormalities (e.g. fluorescent in ... assay, hybrid-capture-selected deoxyribonucleic acid (DNA) libraries are ...

6. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   Measurable light chains by free light chain assay; Measurable plasmacytoma; Monoclonal plasma cells in bone marrow. Eastern Cooperative Oncology Group (ECOG) ...

7. Publications - Nathanael G. Bailey, M.D. - Mayo Clinic

   Visualization of the Effect of Assay Size on the Error Profile of Tumor Mutational Burden Measurement. ... assays. Appl Immunohistochem Mol Morphol. 2015 ...

8. Mayo Clinic researchers develop model to predict treatment response in gastric cancer

   Hwang and his team also are working to develop new assays based on the expression level of a single ― or several ― genes to make biomarkers more accessible and ...

9. Mayo Clinic, Terasaki Institute launch collaboration for transplant innovation

   That will be done by creating prognostic signatures and assays for antibody-mediated rejection of organ transplant. These initial projects are expected to ...

10. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

    Serum Free light chain (FLC) assay: Involved FLC level >=10 mg/dL (>=100 mg/L) and an abnormal serum free light chain ratio (<0.26 or >1.65). Subjects with ...